Sleep Apnea Treatment With Expiratory Resistance(Provent™)

Exclusion Criteria

• •Total sleep time from previous sleep study \< 4 hours (240 minutes)
• •Severe bilateral nasal obstruction (apparent mouth breathing at rest)
• •Documented history of lung diseases, as defined below:
• •Daytime hypercapnia (PaCO2 \> 45 mmHg)
• •Baseline SaO2 ≤ 92%
• •Chronic lung disease except mild intermittent or mild persistent asthma
• •Cor pulmonale
• •Documented clinical cardiovascular disease, as defined below:
• •Myocardial infarction in past 3 months
• •Revascularization procedure in past 3 months
• •Implanted cardiac pacemaker or ICD
• •Unstable arrhythmias
• •Congestive heart failure with ejection fraction \< 40%
• •Uncontrolled hypertension (BP \> 190/110)
• •History of end stage renal disease (on dialysis)
• •History of end stage liver disease, such as:
• •Jaundice
• •Ascites
• •History of recurrent gastrointestinal bleeding
• •Transjugular intrahepatic portosystemic shunt (TIPS) ;
• •Sleep disorders other than obstructive sleep apnea, such as:
• •Narcolepsy
• •Restless leg syndrome
• •Periodic limb movements causing an arousal index of \> 5 per hour
• •Transportation industry worker (commercial truck or bus drivers, airline pilots)
• •Known pregnancy (by self report)
• •Known coagulopathy or anticoagulant use (e.g. coumadin) other than aspirin.
• •Allergy to lidocaine